GRI
USDGRI Bio Inc. Common Stock
$1.680-0.080 (-4.545%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.760
最高
$1.760
最低
$1.600
交易量
0.06M
公司基本面
市值
4.2M
行業
生物科技
國家
United States
交易統計
平均交易量
1.17M
交易所
NCM
貨幣
USD
52週範圍
最低 $1.1當前 $1.680最高 $16.949
相關新聞
Analyst Upgrades
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35
Ascendiant Capital analyst Edward Woo maintains GRI Bio with a Buy and raises the price target from $34 to $35.
查看更多
GlobeNewswire
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are
查看更多
相關股票
ETG
Eaton Vance Tax-Advantaged Global Dividend Income Fund Common Shares of Beneficial Interest
NASDAQ
投資經理
SVII
Spring Valley Acquisition Corp. II Ordinary Shares
NASDAQ
空白支票
ALSA
Alpha Star Acquisition Corporation Ordinary Shares
NASDAQ
空白支票
MD
Pediatrix Medical Group Inc.
NASDAQ
Hospital/Nursin...
NVRI
Enviri Corporation
NASDAQ
多元化商業服務
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。